Adam S Cheifetz

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Capsule endoscopy retention: is it a complication?
    Adam S Cheifetz
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    J Clin Gastroenterol 40:688-91. 2006
  2. doi request reprint Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups
    A S Cheifetz
    Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Inflamm Bowel Dis 18:2294-300. 2012
  3. doi request reprint Management of active Crohn disease
    Adam S Cheifetz
    Division of Gastroenterology, Rabb Rose 425, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA
    JAMA 309:2150-8. 2013
  4. doi request reprint Cyclosporine is safe and effective in patients with severe ulcerative colitis
    Adam S Cheifetz
    Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    J Clin Gastroenterol 45:107-12. 2011
  5. pmc Histologic markers of inflammation in patients with ulcerative colitis in clinical remission
    Laura Rosenberg
    Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Gastroenterol Hepatol 11:991-6. 2013
  6. doi request reprint Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel disease
    Sonia Friedman
    Division of Gastroenterology, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Inflamm Bowel Dis 19:534-9. 2013
  7. doi request reprint High self-efficacy predicts adherence to surveillance colonoscopy in inflammatory bowel disease
    Sonia Friedman
    Department of Medicine, Division of Gastroenterology, Brigham and Women s Hospital Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center Department of Medicine, Section of Gastroenterology, Boston Medical Center, Boston, Massachusetts and Department of Analysis and Information Management, University of California, Los Angeles, California
    Inflamm Bowel Dis 20:1602-10. 2014
  8. doi request reprint The utility of capsule endoscopy in patients with suspected Crohn's disease
    Melissa Tukey
    Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
    Am J Gastroenterol 104:2734-9. 2009
  9. doi request reprint Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in interventional medicine subspecialty guidelines
    Joseph D Feuerstein
    Department of Medicine and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA Electronic address
    Mayo Clin Proc 89:16-24. 2014
  10. pmc Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease
    Glen A Doherty
    Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Inflamm Bowel Dis 18:1608-16. 2012

Collaborators

Detail Information

Publications39

  1. ncbi request reprint Capsule endoscopy retention: is it a complication?
    Adam S Cheifetz
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    J Clin Gastroenterol 40:688-91. 2006
    ....
  2. doi request reprint Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups
    A S Cheifetz
    Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Inflamm Bowel Dis 18:2294-300. 2012
    ..We developed a priority list of CER topics for inflammatory bowel disease (IBD)...
  3. doi request reprint Management of active Crohn disease
    Adam S Cheifetz
    Division of Gastroenterology, Rabb Rose 425, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA
    JAMA 309:2150-8. 2013
    ..Knowing how to treat individual patients in this quickly changing milieu can be a challenge...
  4. doi request reprint Cyclosporine is safe and effective in patients with severe ulcerative colitis
    Adam S Cheifetz
    Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    J Clin Gastroenterol 45:107-12. 2011
    ..The aim of this study was to assess the long-term colectomy-sparing effects and safety of CSA in patients hospitalized for ulcerative colitis...
  5. pmc Histologic markers of inflammation in patients with ulcerative colitis in clinical remission
    Laura Rosenberg
    Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Gastroenterol Hepatol 11:991-6. 2013
    ..We investigated patterns of histologic features of inflammation in patients with UC in clinical remission, and correlated these with endoscopic and biochemical measures of inflammation...
  6. doi request reprint Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel disease
    Sonia Friedman
    Division of Gastroenterology, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Inflamm Bowel Dis 19:534-9. 2013
    ..Patients with extensive ulcerative colitis or Crohn's disease of the colon have an increased risk of colon cancer and require colonoscopic surveillance. This study explores factors that affect adherence to surveillance colonoscopy...
  7. doi request reprint High self-efficacy predicts adherence to surveillance colonoscopy in inflammatory bowel disease
    Sonia Friedman
    Department of Medicine, Division of Gastroenterology, Brigham and Women s Hospital Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center Department of Medicine, Section of Gastroenterology, Boston Medical Center, Boston, Massachusetts and Department of Analysis and Information Management, University of California, Los Angeles, California
    Inflamm Bowel Dis 20:1602-10. 2014
    ..In this study, we assessed individual self-efficacy (SE) to estimate the probability of adherence to surveillance colonoscopies...
  8. doi request reprint The utility of capsule endoscopy in patients with suspected Crohn's disease
    Melissa Tukey
    Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
    Am J Gastroenterol 104:2734-9. 2009
    ..We sought to determine the utility of CE for the subsequent diagnosis of CD in patients suspected to have this condition...
  9. doi request reprint Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in interventional medicine subspecialty guidelines
    Joseph D Feuerstein
    Department of Medicine and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA Electronic address
    Mayo Clin Proc 89:16-24. 2014
    ..To determine the validity of guidelines published by interventional medical societies...
  10. pmc Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease
    Glen A Doherty
    Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Inflamm Bowel Dis 18:1608-16. 2012
    ..The optimal strategy is unknown. The aim was to evaluate the comparative cost-effectiveness of postoperative strategies to prevent clinical recurrence of CD...
  11. doi request reprint Prevalence and lifetime risk of endoscopy-related complications among patients with inflammatory bowel disease
    Jason Ferreira
    Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts Electronic address
    Clin Gastroenterol Hepatol 11:1288-93. 2013
    ..We aimed to determine the prevalence of procedure-related complications among these patients, compared with the general population, and estimate the lifetime risk of colonoscopy-related complications...
  12. ncbi request reprint Barriers to mesalamine adherence in patients with inflammatory bowel disease: a qualitative analysis
    Jennifer Devlen
    Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 022156, USA
    J Manag Care Spec Pharm 20:309-14. 2014
    ..The causes for nonadherence to mesalamine in patients with inflammatory bowel disease (IBD) have been characterized using mostly indirect methods. Patient-reported barriers are lacking in this population...
  13. pmc Predictors of endoscopic inflammation in patients with ulcerative colitis in clinical remission
    Laura Rosenberg
    Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Inflamm Bowel Dis 19:779-84. 2013
    ..The goal of this study was to determine the prevalence of active endoscopic disease, and factors associated with it, in patients with UC who are in clinical remission...
  14. doi request reprint Management of acute severe ulcerative colitis
    Glen A Doherty
    Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
    Expert Rev Gastroenterol Hepatol 3:395-405. 2009
    ..Surgery is unavoidable in some cases, but is the treatment of choice in others. While ileal pouch-anal anastomosis offers the prospect of life without a permanent ileostomy, there are issues with its long-term functional outcome...
  15. doi request reprint Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals
    Pascal Juillerat
    Department of Gastroenterology and Hepatology, MGH Crohn s and Colitis Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts Division of Gastroenterology, Clinic of Visceral Surgery and Medicine, Bern University Hospital Inselspital, Bern, Switzerland Gastroenterology, Boston University School of Medicine, Boston, Massachusetts Division of Gastroenterology, Brigham and Women s Hospital, Boston, Massachusetts Gastroenterology, Lahey Clinic, Burlington, Massachusetts Gastroenterology, University of Massachusetts, Worcester, Massachusetts and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    Inflamm Bowel Dis 19:2457-63. 2013
    ..The purpose of this study was to perform a descriptive analysis of a series of CD patients not currently enrolled in a clinical trial...
  16. doi request reprint Evaluation of the small bowel in inflammatory bowel disease
    Garret Cullen
    Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Expert Rev Gastroenterol Hepatol 7:239-51. 2013
    ..This review summarizes the evidence for the various techniques for evaluating the small bowel in IBD...
  17. pmc CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel disease
    Glen A Doherty
    Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Eur J Immunol 42:3062-72. 2012
    ..We conclude that the CD73(+) CD4(+) T-cell population in patients with active IBD are enriched with cells with a T-helper type 17 phenotype, and could be used to monitor disease activity during treatment...
  18. doi request reprint A random urine test can identify patients at risk of mesalamine non-adherence: a prospective study
    Anne E Gifford
    Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Am J Gastroenterol 108:249-55. 2013
    ..Our aim is to determine whether measurement of salicylates in a random urine sample correlates with 5-ASA levels, and predicts an individual's risk of mesalamine non-adherence...
  19. doi request reprint Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis--a prospective study
    Alan C Moss
    Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Rose 1 East, BIDMC, 330 Brookline Ave, Boston, MA 02215, United States
    J Crohns Colitis 4:171-5. 2010
    ..We sought to determine whether a nurse-delivered patient-support program could improve medication adherence in these patients...
  20. doi request reprint Impact of concomitant immunomodulator use on long-term outcomes in patients receiving scheduled maintenance infliximab
    Alan C Moss
    Harvard Medical School, Beth Israel Deaconess Medical Center, Center for Inflammatory Bowel Disease, Rabb 4 East, BIDMC, 330 Brookline Ave, Boston, MA 02215, USA
    Dig Dis Sci 55:1413-20. 2010
    ..4, 95% CI 0.1-1.5, P = 0.1). The combination of maintenance infliximab and an immunomodulator produced modest improvements in outcomes beyond maintenance infliximab alone in this cohort...
  21. ncbi request reprint Combined oral and topical mesalazine treatment for extensive ulcerative colitis
    Alan C Moss
    Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Nat Clin Pract Gastroenterol Hepatol 3:290-3. 2006
    ..6 g/day. The severity of symptoms had affected her plans to have children...
  22. doi request reprint Documented compliance with inflammatory bowel disease quality measures is poor
    Joseph D Feuerstein
    Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave E Dana 501, Boston, MA, 02215, USA
    Dig Dis Sci 60:339-44. 2015
    ..Quality metrics allows health care to be standardized and monitored. The American Gastroenterological Association (AGA) established quality metrics for inflammatory bowel disease (IBD) in 2011, but compliance is unknown...
  23. doi request reprint Attitudes to mesalamine questionnaire: a novel tool to predict mesalamine nonadherence in patients with IBD
    Alan C Moss
    Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Am J Gastroenterol 109:1850-5. 2014
    ..We sought to develop a valid tool to identify barriers to patient adherence and predict those at risk for future nonadherence...
  24. doi request reprint Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in gastroenterology practice guidelines
    Joseph D Feuerstein
    Department of Medicine and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Am J Gastroenterol 108:1686-93. 2013
    ..We examined the guidelines for quality of evidence, methods of grading evidence, and conflicts of interest (COIs)...
  25. doi request reprint Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease
    Mona Akbari
    Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Inflamm Bowel Dis 19:15-22. 2013
    ..We performed a systematic review and meta-analysis to evaluate the effects of thiopurine exposure during pregnancy or at the time of conception on three measures of fetal risk in women and men with IBD...
  26. doi request reprint Varicella zoster virus infection in inflammatory bowel disease
    Garret Cullen
    Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Inflamm Bowel Dis 18:2392-403. 2012
    ..Varicella zoster virus (VZV) is of particular interest in IBD because of a number of reports of severe, disseminated, and occasionally fatal varicella infection in immunosuppressed IBD patients...
  27. doi request reprint Abdominal phlegmons in Crohn's disease: outcomes following antitumor necrosis factor therapy
    Garret Cullen
    Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts Harvard Medical School, Boston, Massachusetts 02215, USA
    Inflamm Bowel Dis 18:691-6. 2012
    ..The aim of this study was to examine outcomes for patients with CD who developed an abdominal phlegmon that was subsequently treated with an anti-TNF antibody...
  28. doi request reprint Utility of CT in the emergency department in patients with ulcerative colitis
    Laurie Gashin
    Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts and Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    Inflamm Bowel Dis 21:793-800. 2015
    ..In this study, we assess the frequency and risk factors for clinically significant CT findings in patients with UC in the ED...
  29. pmc Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypes
    Parham Safaie
    Liver Disease Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts and Department of Microbiology and Immunology, Drexel College of Medicine, Pennsylvania Biotechnology Center, Philadelphia, Pennsylvania
    Inflamm Bowel Dis 19:2796-800. 2013
    ..The aim was to describe the relationship between circulating levels of a subset of agalactosyl IgGs (anti-α-Gal) and Crohn's disease (CD) phenotypes...
  30. pmc The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model
    Jennifer Devlen
    Oxford Outcomes, ICON plc Company, Bethesda, Maryland Outcomes Research Strategies in Health LLC, Washington, District of Columbia Shire Development LLC, Wayne, Pennsylvania and Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    Inflamm Bowel Dis 20:545-52. 2014
    ..The aim of this study was to describe the impacts of inflammatory bowel disease (IBD) from the patients' perspective and to inform the development of a conceptual model...
  31. pmc Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis
    Siddharth P Sura
    Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA Division of Gastroenterology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA
    J Clin Gastroenterol 48:351-5. 2014
    ..We investigated the performance of serology testing in predicting future diagnosis in this setting...
  32. ncbi request reprint The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease
    Adam S Cheifetz
    Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Am J Gastroenterol 101:2218-22. 2006
    ..Our goal was to determine the risk of capsule retention in patients with suspected or known CD...
  33. pmc Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis
    Kavinderjit S Nanda
    Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Am J Gastroenterol 108:40-7; quiz 48. 2013
    ..The objective of this study was to perform a systematic review and meta-analysis of studies that reported clinical outcomes and IFX levels according to patients' ATI status...
  34. pmc Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha
    Alan C Moss
    Gastrointestinal Neuropeptide Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Gut 56:1210-7. 2007
    ..UcnII is synthesised in the intestine, but its role in human intestinal inflammation is largely unknown...
  35. doi request reprint Miscellaneous adverse events with biologic agents (excludes infection and malignancy)
    Joseph D Feuerstein
    Division of Gastroenterology, Department of Medicine, Center for Inflammatory Bowel Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Rabb 425, Boston, MA 02215, USA
    Gastroenterol Clin North Am 43:543-63. 2014
    ..In this article, the current knowledge regarding the noninfectious and nonmalignant toxicities associated with anti-TNF agents is summarized. ..
  36. doi request reprint Proactive therapeutic concentration monitoring of infliximab may improve outcomes for patients with inflammatory bowel disease: results from a pilot observational study
    Byron P Vaughn
    Center for Inflammatory Bowel Diseases, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts and Division of Gastroenterology, University of California San Diego, La Jolla, California
    Inflamm Bowel Dis 20:1996-2003. 2014
    ..Infliximab (IFX) is effective in the treatment of inflammatory bowel disease; however, the effect is often not durable. It is unknown if proactive therapeutic concentration monitoring (TCM) of IFX improves outcomes...
  37. doi request reprint Ulcerative colitis: epidemiology, diagnosis, and management
    Joseph D Feuerstein
    Department of Medicine and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA Electronic address
    Mayo Clin Proc 89:1553-63. 2014
    ....
  38. doi request reprint Doctor message can alter patients' behavior and attitudes regarding inflammatory bowel disease and colon cancer
    Sonia Friedman
    Division of Gastroenterology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Inflamm Bowel Dis 18:1531-9. 2012
    ..This study explores patient attitudes and behavior regarding inflammatory bowel disease (IBD), colonoscopies, and colon cancer risk...
  39. ncbi request reprint Reducing the torment of diarrhea: tormentil for active ulcerative colitis
    Alan C Moss
    J Clin Gastroenterol 41:797-8. 2007